Eric Chadwick
- Role
- Associate Director, Head of in Vivo Pharmacology at Shape Therapeutics Inc
- Location
- Seattle, WA, US
- LinkedIn followers
- 500 followers
About Eric Chadwick
Specialties- in vivo disease models of allergy, inflammation, and autoimmunity …
Experience
Associate Director, Head of in Vivo Pharmacology
Jul 2023 — Present
Shape Therapeutics (Shape Tx) is a development-stage biotechnology company establishing itself as the leader in next-generation gene therapy. Our novel technology platforms enable direct in vivo targeting/modification of RNA by leveraging ADARs (Adenosine Deaminase Acting on RNA), suppressor tRNAs, gene replacement therapy using novel promoter and enhancer elements, and payload delivery with novel adeno-associated viral vectors (AAVs). My primary role is leading a team of talented scientists and research associates in establishing preclinical in vivo studies to advance our technology platforms and to evaluate lead candidates in the relevant disease models.
Skills
- Flow Cytometry
- Inflammation
- Oncology
- Clinical Trials
- In Vitro
- Life Sciences
- Protein Chemistry
- Elisa
- Drug Discovery
- Assay Development
- Immunology
- In Vivo
- Cancer
- Biotechnology
- Cell Culture
- Cell Biology
- Antibodies
- In Vivo Disease Models
Find verified contacts for anyone on LinkedIn
Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.
Free plan included · No credit card required
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.